Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
fda
3
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
novartis
3
×
biogen
biotech
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
crispr
deals
detroit blog main
detroit top stories
gene therapy
indiana blog main
indiana top stories
ipo
meiragtx
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
spinal muscular atrophy
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
2025
abbvie
What
years
3
×
bio
deal
ipo
roundup
acquisitions
age
allogene
announced
bigger
biggest
cancer
ceo
collabs
come
covid
crispr
daniel
diversity
emerging
gave
gene
gilead
gilead’s
help
hot
immunotherapy
introduce
investors
j
johnson
juno
medicines
meiragtx
million
month
morning
nearly
new
o’day
Language
unset
Current search:
years
×
fda
×
novartis
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More